SOLI: SEC Suspension "because of questions regarding the accuracy and adequacy of information in the marketplace since at least March 16, 2020. Those questions relate to statements SOLI made, in a press release issued by the Company on March 16, 2020 and a March 18, 2020 national cable news program interview with the Chief Executive Officer of its wholly-owned subsidiary, CareClix, Inc., about the ability of CareClix to provide COVID-19 testing kits that would allow a patient to submit a testing sample from home."